retatrutide phase 2 nejm 2023 weight loss percent 48 weeks

retatrutide phase 2 nejm 2023 weight loss percent 48 weeks Trial of for Obesity Retatrutide vs Wegovy: which works

Name: retatrutide phase 2 nejm 2023 weight loss percent 48 weeks Trial of for Obesity Retatrutide vs Wegovy: which works
Brand: www.keygrove.com
SKU: 43886250949
Price: 26.57 USD
Availability: InStock
Rating: 4.0792 (13 reviews)

SKU: 43886250949

4.1

EUR26.57 EUR48.57

Pay in 4 interest-free payments of $6.64 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 9 - Aug 14

Description

This creates a coverage gap

But it remains early data

This occurs because growth hormones can influence metabolic rate and blood sugar regulation

Earlier evidence for retatrutide comes from a Phase 2 trial in NEJM in 2023, which reported 24.2% weight loss at 12 mg over 48 weeks

They are also contraindicated in those with personal or family history of medullary thyroid carcinoma and those with multiple endocrine neoplasia type 2